Aadi starts from scratch as it sells assets, licenses ADCs and raises new funds

In a major reset to round off the year, Aadi Bioscience is divesting its only marketed product and in-licensing a trio of ADCs developed by WuXi Biologics and another Chinese biotech. Aadi has inked an ...